The Hospital Immune System. Built to stop outbreaks before they start.
Claryx has raised $3.5M in total funding. The most recent round was Pre-Seed. The last funding was announced in August 2026.
Claryx's investors include Precursor Ventures, Outlander VC, Company Ventures, Neon, Mana Ventures.
Claryx is headquartered in New York, United States.
The Hospital Immune System. Built to stop outbreaks before they start.
Claryx is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Claryx — Funding & Investors." VCBacked, August 4, 2026, https://www.vcbacked.co/company/claryx. Accessed September 1, 2026.
VCBacked. (2026). Claryx — Funding & Investors. Retrieved September 1, 2026, from https://www.vcbacked.co/company/claryx
{{cite web |title=Claryx — Funding & Investors |url=https://www.vcbacked.co/company/claryx |website=VCBacked |access-date=September 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated